Benefits and challenges with diagnosing chronic and late acute GVHD in children using the NIH consensus criteriaGeoff D.E. Cuvelier, Kirk R. Schultz, Joseph H. Chewning et al.|Blood|2019Cited by 89
Immune profile differences between chronic GVHD and late acute GVHD: results of the ABLE/PBMTC 1202 studiesKirk R. Schultz, Geoff D.E. Cuvelier, Amina Kariminia et al.|Blood|2020Cited by 67
Ibrutinib Treatment of Pediatric Chronic Graft-versus-Host Disease: Primary Results from the Phase 1/2 iMAGINE StudyPaul A. Carpenter, Jean‐Hugues Dalle, Hyoung Jin Kang et al.|Transplantation and Cellular Therapy|2022Cited by 31
Tabelecleucel for EBV+ PTLD after allogeneic HCT or SOT in a multicenter expanded access protocolSarah Nikiforow, Susan E. Prockop, Jennifer Whangbo et al.|Blood Advances|2024Cited by 23
Naïve Helper T-Cell and Regulatory T- and NK-Cell Subsets Are Associated with Pediatric Chronic Graft-Versus-Host Disease: Results of the ABLE / PBMTC 1202 StudyGeoff D.E. Cuvelier, Kirk R. Schultz, Amina Kariminia et al.|Blood|2020Cited by 2